MIR506 induces autophagy-related cell death in pancreatic cancer cells by targeting the STAT3 pathway

References

• Ryan DP, Hong TS, Bardeesy N. Pancreatic adenocarcinoma. N Engl J Med 2014; 371:1039-49; PMID:25207767; http://dx.doi.org/10.1056/NEJMra1404198
   PubMed Web of Science ®Google Scholar
• Siegel RL, Miller KD, Jemal A. Cancer statistics, 2015. CA Cancer J Clin 2015; 65:5-29; http://dx.doi.org/10.3322/caac.21254
   PubMed Web of Science ®Google Scholar
• Neoptolemos JP. Adjuvant treatment of pancreatic cancer. Eur J Cancer 2011; 47 Suppl 3:S378-80; PMID:21944022; http://dx.doi.org/10.1016/S0959-8049(11)70210-6
   PubMedGoogle Scholar
• Barugola G, Partelli S, Marcucci S, Sartori N, Capelli P, Bassi C, Pederzoli P, Falconi M. Resectable pancreatic cancer: who really benefits from resection? Ann Surg Oncol 2009; 16:3316-22; PMID:19707831; http://dx.doi.org/10.1245/s10434-009-0670-7
   PubMed Web of Science ®Google Scholar
• Conroy T, Desseigne F, Ychou M, Bouché O, Guimbaud R, Bécouarn Y, Adenis A, Raoul JL, Gourgou-Bourgade S, de la Fouchardière C, et al. FOLFIRINOX versus gemcitabine for metastatic pancreatic cancer. N Engl J Med 2011; 364:1817-25; PMID:21561347; http://dx.doi.org/10.1056/NEJMoa1011923
   PubMed Web of Science ®Google Scholar
• Hale AN, Ledbetter DJ, Gawriluk TR, Rucker EB 3rd. Autophagy: regulation and role in development. Autophagy 2013; 9:951-72; PMID:24121596; http://dx.doi.org/10.4161/auto.24273
   PubMed Web of Science ®Google Scholar
• Rabinowitz JD, White E. Autophagy and metabolism. Science 2010; 330:1344-8; PMID:21127245; http://dx.doi.org/10.1126/science.1193497
   PubMed Web of Science ®Google Scholar
• Ito H, Aoki H, Kühnel F, Kondo Y, Kubicka S, Wirth T, Iwado E, Iwamaru A, Fujiwara K, Hess KR, et al. Autophagic cell death of malignant glioma cells induced by a conditionally replicating adenovirus. J Natl Cancer Inst 2006; 98:625-36; PMID:16670388; http://dx.doi.org/10.1093/jnci/djj161
   PubMed Web of Science ®Google Scholar
• Yu L, Alva A, Su H, Dutt P, Freundt E, Welsh S, Baehrecke EH, Lenardo MJ. Regulation of an ATG7-beclin 1 program of autophagic cell death by caspase-8. Science 2004; 304:1500-2; PMID:15131264; http://dx.doi.org/10.1126/science.1096645
   PubMed Web of Science ®Google Scholar
• Kroemer G, Levine B. Autophagic cell death: the story of a misnomer. Nat Rev Mol Cell Biol 2008; 9:1004-10; PMID:18971948; http://dx.doi.org/10.1038/nrm2529
   PubMed Web of Science ®Google Scholar
• Berry DL, Baehrecke EH. Autophagy functions in programmed cell death. Autophagy 2008; 4:359-60; PMID:18212526; http://dx.doi.org/10.4161/auto.5575
   PubMed Web of Science ®Google Scholar
• Pattingre S, Tassa A, Qu X, Garuti R, Liang XH, Mizushima N, Packer M, Schneider MD, Levine B. Bcl-2 antiapoptotic proteins inhibit Beclin 1-dependent autophagy. Cell 2005; 122:927-39; PMID:16179260; http://dx.doi.org/10.1016/j.cell.2005.07.002
   PubMed Web of Science ®Google Scholar
• Akar U, Chaves-Reyez A, Barria M, Tari A, Sanguino A, Kondo Y, Kondo S, Arun B, Lopez-Berestein G, Ozpolat B. Silencing of Bcl-2 expression by small interfering RNA induces autophagic cell death in MCF-7 breast cancer cells. Autophagy 2008; 4:669-79; PMID:18424910; http://dx.doi.org/10.4161/auto.6083
   PubMed Web of Science ®Google Scholar
• Shimizu S, Kanaseki T, Mizushima N, Mizuta T, Arakawa-Kobayashi S, Thompson CB, Tsujimoto Y. Role of Bcl-2 family proteins in a non-apoptotic programmed cell death dependent on autophagy genes. Nat Cell Biol 2004; 6:1221-8; PMID:15558033; http://dx.doi.org/10.1038/ncb1192
   PubMed Web of Science ®Google Scholar
• Yang A, Rajeshkumar NV, Wang X, Yabuuchi S, Alexander BM, Chu GC, Von Hoff DD, Maitra A, Kimmelman AC. Autophagy is critical for pancreatic tumor growth and progression in tumors with p53 alterations. Cancer Discov 2014; 4:905-13; PMID:24875860; http://dx.doi.org/10.1158/2159-8290.CD-14-0362
   PubMed Web of Science ®Google Scholar
• Yang J, Chatterjee-Kishore M, Staugaitis SM, Nguyen H, Schlessinger K, Levy DE, Stark GR. Novel roles of unphosphorylated STAT3 in oncogenesis and transcriptional regulation. Cancer Res 2005; 65:939-47; PMID:15705894
   PubMed Web of Science ®Google Scholar
• Kang R, Tang D, Lotze MT, Zeh HJ 3rd. AGER/RAGE-mediated autophagy promotes pancreatic tumorigenesis and bioenergetics through the IL6-pSTAT3 pathway. Autophagy 2012; 8:989-91; PMID:22722139; http://dx.doi.org/10.4161/auto.20258
   PubMed Web of Science ®Google Scholar
• Gong J, Muñoz AR, Chan D, Ghosh R, Kumar AP. STAT3 down regulates LC3 to inhibit autophagy and pancreatic cancer cell growth. Oncotarget 2014; 5:2529-41; PMID:24796733; http://dx.doi.org/10.18632/oncotarget.1810
   PubMed Web of Science ®Google Scholar
• Niso-Santano M, Shen S, Adjemian S, Malik SA, Mariño G, Lachkar S, Senovilla L, Kepp O, Galluzzi L, Maiuri MC, et al. Direct interaction between STAT3 and EIF2AK2 controls fatty acid-induced autophagy. Autophagy 2013; 9:415-7; PMID:23221979; http://dx.doi.org/10.4161/auto.22910
   PubMed Web of Science ®Google Scholar
• Huang YH, Yang PM, Chuah QY, Lee YJ, Hsieh YF, Peng CW, Chiu SJ. Autophagy promotes radiation-induced senescence but inhibits bystander effects in human breast cancer cells. Autophagy 2014; 10:1212-28; PMID:24813621; http://dx.doi.org/10.4161/auto.28772
   PubMed Web of Science ®Google Scholar
• Maycotte P, Gearheart CM, Barnard R, Aryal S, Mulcahy Levy JM, Fosmire SP, Hansen RJ, Morgan MJ, Porter CC, Gustafson DL, et al. STAT3-mediated autophagy dependence identifies subtypes of breast cancer where autophagy inhibition can be efficacious. Cancer Res 2014; 74:2579-90; PMID:24590058; http://dx.doi.org/10.1158/0008-5472.CAN-13-3470
   PubMed Web of Science ®Google Scholar
• Yokoyama T, Kondo Y, Kondo S. Roles of mTOR and STAT3 in autophagy induced by telomere 3′ overhang-specific DNA oligonucleotides. Autophagy 2007; 3:496-8; PMID:17617738; http://dx.doi.org/10.4161/auto.4602
   PubMed Web of Science ®Google Scholar
• Yoon S, Woo SU, Kang JH, Kim K, Kwon MH, Park S, Shin HJ, Gwak HS, Chwae YJ. STAT3 transcriptional factor activated by reactive oxygen species induces IL6 in starvation-induced autophagy of cancer cells. Autophagy 2010; 6:1125-38; PMID:20930550; http://dx.doi.org/10.4161/auto.6.8.13547
   PubMed Web of Science ®Google Scholar
• Noman MZ, Janji B, Kaminska B, Van Moer K, Pierson S, Przanowski P, Buart S, Berchem G, Romero P, Mami-Chouaib F, et al. Blocking hypoxia-induced autophagy in tumors restores cytotoxic T-cell activity and promotes regression. Cancer Res 2011; 71:5976-86; PMID:21810913; http://dx.doi.org/10.1158/0008-5472.CAN-11-1094
   PubMed Web of Science ®Google Scholar
• Zhang T, Li Y, Park KA, Byun HS, Won M, Jeon J, Lee Y, Seok JH, Choi SW, Lee SH, et al. Cucurbitacin induces autophagy through mitochondrial ROS production which counteracts to limit caspase-dependent apoptosis. Autophagy 2012; 8:559-76; PMID:22441021; http://dx.doi.org/10.4161/auto.18867
   PubMed Web of Science ®Google Scholar
• Yang D, Sun Y, Hu L, Zheng H, Ji P, Pecot CV, Zhao Y, Reynolds S, Cheng H, Rupaimoole R, et al. Integrated analyses identify a master microRNA regulatory network for the mesenchymal subtype in serous ovarian cancer. Cancer Cell 2013; 23:186-99; PMID:23410973; http://dx.doi.org/10.1016/j.ccr.2012.12.020
   PubMed Web of Science ®Google Scholar
• Sun Y, Hu L, Zheng H, Bagnoli M, Guo Y, Rupaimoole R, Rodriguez-Aguayo C, Lopez-Berestein G, Ji P, Chen K, et al. MiR-506 inhibits multiple targets in the epithelial-to-mesenchymal transition network and is associated with good prognosis in epithelial ovarian cancer. J Pathol 2015; 235:25-36; PMID:25230372; http://dx.doi.org/10.1002/path.4443
   PubMed Web of Science ®Google Scholar
• Liu G, Sun Y, Ji P, Li X, Cogdell D, Yang D, Parker Kerrigan BC, Shmulevich I, Chen K, Sood AK, et al. MiR-506 suppresses proliferation and induces senescence by directly targeting the CDK4/6-FOXM1 axis in ovarian cancer. J Pathol 2014; 233:308-18; PMID:24604117; http://dx.doi.org/10.1002/path.4348
   PubMed Web of Science ®Google Scholar
• Wen SY, Lin Y, Yu YQ, Cao SJ, Zhang R, Yang XM, Li J, Zhang YL, Wang YH, Ma MZ, et al. miR-506 acts as a tumor suppressor by directly targeting the hedgehog pathway transcription factor Gli3 in human cervical cancer. Oncogene 2015; 34:717-25; PMID:24608427; http://dx.doi.org/10.1038/onc.2014.9
   PubMed Web of Science ®Google Scholar
• Liu G, Yang D, Rupaimoole R, Pecot CV, Sun Y, Mangala LS, Li X, Ji P, Cogdell D, Hu L, et al. Augmentation of response to chemotherapy by microRNA-506 through regulation of RAD51 in serous ovarian cancers. J Natl Cancer Inst 2015; 107:djv108; PMID:25995442; http://dx.doi.org/10.1093/jnci/djv108
   PubMedGoogle Scholar
• Li J, Wu H, Li W, Yin L, Guo S, Xu X, Ouyang Y, Zhao Z, Liu S, Tian Y, et al. Downregulated miR-506 expression facilitates pancreatic cancer progression and chemoresistance via SPHK1/Akt/NF-κB signaling. Oncogene 2016; 35(42):5501-5514. [ Epub ahead of print]; PMID:27065335; http://dx.doi.org/10.1038/onc.2016.90
   PubMed Web of Science ®Google Scholar
• Du J, Zheng X, Cai S, Zhu Z, Tan J, Hu B, Huang Z, Jiao H. MicroRNA-506 participates in pancreatic cancer pathogenesis by targeting PIM3. Mol Med Rep 2015; 12:5121-6; PMID:26238203
   PubMed Web of Science ®Google Scholar
• Peng T, Zhou L, Zuo L, Luan Y. miR-506 functions as a tumor suppressor in glioma by targeting STAT3. Oncol Rep 2016; 35:1057-64; PMID:26554866
   PubMed Web of Science ®Google Scholar
• Aits S, Kricker J, Liu B, Ellegaard AM, Hämälistö S, Tvingsholm S, Corcelle-Termeau E, Høgh S, Farkas T, Holm Jonassen A, et al. Sensitive detection of lysosomal membrane permeabilization by lysosomal galectin puncta assay. Autophagy 2015; 11:1408-24; PMID:26114578; http://dx.doi.org/10.1080/15548627.2015.1063871
   PubMed Web of Science ®Google Scholar
• Klionsky DJ, Abdelmohsen K, Abe A, Abedin MJ, Abeliovich H, Acevedo Arozena A, Adachi H, Adams CM, Adams PD, Adeli K, et al. Guidelines for the use and interpretation of assays for monitoring autophagy (3rd edition). Autophagy 2016; 12:1-222; PMID:26799652; http://dx.doi.org/10.1080/15548627.2015.1100356
   PubMed Web of Science ®Google Scholar
• Mathew R, Karantza-Wadsworth V, White E. Role of autophagy in cancer. Nat Rev Cancer 2007; 7:961-7; PMID:17972889; http://dx.doi.org/10.1038/nrc2254
   PubMed Web of Science ®Google Scholar
• Høyer-Hansen M, Jäättelä M. Autophagy: an emerging target for cancer therapy. Autophagy 2008; 4:574-80; PMID:18362515; http://dx.doi.org/10.4161/auto.5921
   PubMed Web of Science ®Google Scholar
• Neesse A, Michl P, Frese KK, Feig C, Cook N, Jacobetz MA, Lolkema MP, Buchholz M, Olive KP, Gress TM, et al. Stromal biology and therapy in pancreatic cancer. Gut 2011; 60:861-8; PMID:20966025; http://dx.doi.org/10.1136/gut.2010.226092
   PubMed Web of Science ®Google Scholar
• Noman MZ, Janji B, Berchem G, Mami-Chouaib F, Chouaib S. Hypoxia-induced autophagy: a new player in cancer immunotherapy? Autophagy 2012; 8:704-6; PMID:22441015; http://dx.doi.org/10.4161/auto.19572
   PubMed Web of Science ®Google Scholar
• Azad MB, Chen Y, Henson ES, Cizeau J, McMillan-Ward E, Israels SJ, Gibson SB. Hypoxia induces autophagic cell death in apoptosis-competent cells through a mechanism involving BNIP3. Autophagy 2008; 4:195-204; PMID:18059169; http://dx.doi.org/10.4161/auto.5278
   PubMed Web of Science ®Google Scholar
• Farrall AL, Whitelaw ML. The HIF1 alpha-inducible pro-cell death gene BNIP3 is a novel target of SIM2s repression through cross-talk on the hypoxia response element. Oncogene 2009; 28:3671-80; PMID:19668230; http://dx.doi.org/10.1038/onc.2009.228
   PubMed Web of Science ®Google Scholar
• Morselli E, Galluzzi L, Kepp O, Mariño G, Michaud M, Vitale I, Maiuri MC, Kroemer G. Oncosuppressive functions of autophagy. Antioxid Redox Signal 2011; 14:2251-69; PMID:20712403; http://dx.doi.org/10.1089/ars.2010.3478
   PubMed Web of Science ®Google Scholar
• Cuervo AM, Macian F. Autophagy, nutrition and immunology. Mol Aspects Med 2012; 33:2-13; PMID:21982744; http://dx.doi.org/10.1016/j.mam.2011.09.001
   PubMed Web of Science ®Google Scholar
• Navarro-Yepes J, Burns M, Anandhan A, Khalimonchuk O, del Razo LM, Quintanilla-Vega B, Pappa A, Panayiotidis MI, Franco R. Oxidative stress, redox signaling, and autophagy: cell death versus survival. Antioxid Redox Signal 2014; 21:66-85; PMID:24483238; http://dx.doi.org/10.1089/ars.2014.5837
   PubMed Web of Science ®Google Scholar
• Fujii S, Mitsunaga S, Yamazaki M, Hasebe T, Ishii G, Kojima M, Kinoshita T, Ueno T, Esumi H, Ochiai A. Autophagy is activated in pancreatic cancer cells and correlates with poor patient outcome. Cancer Sci 2008; 99:1813-9; PMID:18616529; http://dx.doi.org/10.1111/j.1349-7006.2008.00743.x
   PubMed Web of Science ®Google Scholar
• Yang S, Wang X, Contino G, Liesa M, Sahin E, Ying H, Bause A, Li Y, Stommel JM, Dell'antonio G, et al. Pancreatic cancers require autophagy for tumor growth. Genes Dev 2011; 25:717-29; PMID:21406549; http://dx.doi.org/10.1101/gad.2016111
   PubMed Web of Science ®Google Scholar
• Zhang G, Park MA, Mitchell C, Hamed H, Rahmani M, Martin AP, Curiel DT, Yacoub A, Graf M, Lee R, et al. Vorinostat and sorafenib synergistically kill tumor cells via FLIP suppression and CD95 activation. Clin Cancer Res 2008; 14:5385-99; PMID:18765530; http://dx.doi.org/10.1158/1078-0432.CCR-08-0469
   PubMed Web of Science ®Google Scholar
• Pardo R, Lo Ré A, Archange C, Ropolo A, Papademetrio DL, Gonzalez CD, Alvarez EM, Iovanna JL, Vaccaro MI. Gemcitabine induces the VMP1-mediated autophagy pathway to promote apoptotic death in human pancreatic cancer cells. Pancreatology 2010; 10:19-26; PMID:20299819; http://dx.doi.org/10.1159/000264680
   PubMed Web of Science ®Google Scholar
• Sheikh R, Walsh N, Clynes M, O'Connor R, McDermott R. Challenges of drug resistance in the management of pancreatic cancer. Expert Rev Anticancer Ther 2010; 10:1647-61; PMID:20942635; http://dx.doi.org/10.1586/era.10.148
   PubMed Web of Science ®Google Scholar
• Donadelli M, Dando I, Zaniboni T, Costanzo C, DallaPozza E, Scupoli MT, Scarpa A, Zappavigna S, Marra M, Abbruzzese A, et al. Gemcitabine/cannabinoid combination triggers autophagy in pancreatic cancer cells through a ROS-mediated mechanism. Cell Death Dis 2011; 2:e152; PMID:21525939; http://dx.doi.org/10.1038/cddis.2011.36
   PubMed Web of Science ®Google Scholar
• Udelnow A, Kreyes A, Ellinger S, Landfester K, Walther P, Klapperstueck T, Wohlrab J, Henne-Bruns D, Knippschild U, Würl P. Omeprazole inhibits proliferation and modulates autophagy in pancreatic cancer cells. PLoS One 2011; 6:e20143; PMID:21629657; http://dx.doi.org/10.1371/journal.pone.0020143
   PubMed Web of Science ®Google Scholar
• Saeki K, Yuo A, Okuma E, Yazaki Y, Susin SA, Kroemer G, Takaku F. Bcl-2 down-regulation causes autophagy in a caspase-independent manner in human leukemic HL60 cells. Cell Death Differ 2000; 7:1263-9; PMID:11175264; http://dx.doi.org/10.1038/sj.cdd.4400759
   PubMed Web of Science ®Google Scholar
• Tai WT, Shiau CW, Chen HL, Liu CY, Lin CS, Cheng AL, Chen PJ, Chen KF. Mcl-1-dependent activation of Beclin 1 mediates autophagic cell death induced by sorafenib and SC-59 in hepatocellular carcinoma cells. Cell Death Dis 2013; 4:e485; PMID:23392173; http://dx.doi.org/10.1038/cddis.2013.18
   PubMed Web of Science ®Google Scholar
• Kang Y, Zhang R, Suzuki R, Li SQ, Roife D, Truty MJ, Chatterjee D, Thomas RM, Cardwell J, Wang Y, et al. Two-dimensional culture of human pancreatic adenocarcinoma cells results in an irreversible transition from epithelial to mesenchymal phenotype. Lab Invest 2015; 95:207-22; PMID:25485535; http://dx.doi.org/10.1038/labinvest.2014.143
   PubMed Web of Science ®Google Scholar